TMBIM1 ameliorates sepsis‐induced cardiac dysfunction by promoting Parkin‐mediated mitophagy
The FASEB Journal · 28.02.2025 · 39 (4)
DOI: 10.1096/fj.202402599rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 12.02.2025. Verfasst von Weichang Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Mitophagy, Sepsis, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Scientific and Technological Planning Project of Guangzhou City, China Postdoctoral Foundation Project | Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation).
Themen: Sepsis
Abstract (Originalsprache)
Myocardial dysfunction is a significant complication of sepsis that is associated with elevated mortality rates. Transmembrane BAX inhibitor motif containing 1 (TMBIM1), a stress‐responsive protein, has garnered interest in the field of cardiovascular disease for its cardioprotective properties. Nevertheless, the role of TMBIM1 on sepsis‐induced cardiac dysfunction (SICD) remains unknown. Here, our findings revealed a significant elevation in TMBIM1 expression within the myocardium following endotoxin challenge and further demonstrate the cardioprotective effects of TMBIM1 through adenovirus‐mediated gene manipulation. Notably, lipopolysaccharide exposure markedly induced mitochondrial dysfunction in cardiomyocytes, which was effectively alleviated by TMBIM1 overexpression, while TMBIM1 knockdown exacerbated this dysfunction. Moreover, in cardiomyocytes subjected to endotoxin challenge, TMBIM1 was observed to interact with Parkin, facilitating its translocation from the cytosol to damaged mitochondria. This interaction enhanced the activation of mitophagy, thereby promoting the clearance of dysfunctional mitochondria and subsequently mitigating cellular injury. Hence, targeting TMBIM1 could be a novel therapeutic strategy for treating SICD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Critical Care Medicine, The 10th Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Southern Medical University, Dongguan, China.
- Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, Zhejiang, China.
ORCID-Profile: Weichang Huang, Anni Lou, Jun Wang, Yuegang Wang, Wenyong Zhang, Jierui Li, Shuanghu Wang, Shiyu Geng, Guozhen Wang, Xu Li
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Scientific and Technological Planning Project of Guangzhou City
- China Postdoctoral Foundation Project | Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation)
- GDSTC | Natural Science Foundation of Guangdong Province
- GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province
- Nanfang Hospital
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Huang, W., Lou, A., Wang, J., Wang, Y., Zhang, W., Li, J., Wang, S., Geng, S., Wang, G., & Li, X. (2025). TMBIM1 ameliorates sepsis‐induced cardiac dysfunction by promoting Parkin‐mediated mitophagy. The FASEB Journal, 39(4). https://doi.org/10.1096/fj.202402599rr
Vancouver
Huang W, Lou A, Wang J, Wang Y, Zhang W, Li J, et al. TMBIM1 ameliorates sepsis‐induced cardiac dysfunction by promoting Parkin‐mediated mitophagy. The FASEB Journal. 2025;39(4). doi:10.1096/fj.202402599rr
BibTeX
@article{Huang2025,
author = {Huang, Weichang and Lou, Anni and Wang, Jun and Wang, Yuegang and Zhang, Wenyong and Li, Jierui and Wang, Shuanghu and Geng, Shiyu and Wang, Guozhen and Li, Xu},
title = {TMBIM1 ameliorates sepsis‐induced cardiac dysfunction by promoting Parkin‐mediated mitophagy},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {4},
doi = {10.1096/fj.202402599rr}
}
EUVIMED